Professional Documents
Culture Documents
Adv. Healthcare Mater. 2021, 2101770 SI
Adv. Healthcare Mater. 2021, 2101770 SI
1
Supporting Information
Shengcai Yang, Yanming Wang, Jason Tan, Jye Yng Teo, Ko Hui Tan, and Yi Yan Yang*
2
Figure S1. 1H NMR spectra of (A) PLL35-Gua(Boc) in CDCl3 and (B) PLL35-Gua in DMSO-
d6.
3
Figure S3. 1H NMR spectra of (A) PLL22-Gua(Boc)(64%) in CDCl3 and (B) PLL22-
Gua(64%) in DMSO-d6.
4
Figure S4. 1H NMR spectra of (A) PLL35-Gua(Boc)-VitE in CDCl3 and (B) PLL35-Gua-VitE
in DMSO-d6.
Figure S5. Critical micelle concentration (CMC) of (A) PLL22-Gua-VitE and (B) PLL35-Gua-
VitE in PBS.
5
Scheme S1. Synthesis of p(lys-r-leu).
Figure S6. 1H NMR spectra of (A) p(lys(Z)-r-leu) in TFA-d and (B) p(lys-r-leu) in D2O.
6
Figure S7. GPC traces of (A) p(lys-r-leu) and (B) p(lys(Gua)-r-leu).
Figure S8. 1H NMR spectra of (A) p(lys(Gua(Boc))-r-leu) in CDCl3 and (B) p(lys(Gua)-r-
leu) in D2O.
7
Figure S9. Hemolytic activity of PLL, PLL-Gua, PLL-Gua-VitE, p(lys-r-leu) and p(lys(Gua)-
r-leu). The experiment was performed in triplicates, and the results were expressed as mean
hemolysis (%) standard deviations shown by the error bars.
100
P L L 2 2-G u a
80 PLL22
C e ll V ia b ilit y ( % )
60
40
20
0
h
h
h
4
1
4
2
2
@
@
9
9
2
3
2
9
9
9
2
L
K
E
H
Figure S10. Viability of L929 or HEK293 cells after 24 h of incubation with PLL22 and
PLL22-Gua against at their respective MBC against MRSA.
8
Figure S11. Killing kinetics of vancomycin against MRSA within 3.0 h.
Figure S12. Photo of MRSA-infected wounds. For the establishment of wound infection
model, hair from the back of anaesthetized mice was removed and the exposed skin was
cleansed with 10% povidone-iodine solution and 75% ethanol. Three parallel wounds, with
about 1 cm length, were then created and infected with logarithmic growth of MRSA (1×10 10
CFU/mL, 60 µL) for 1 h prior to treatment.
9
Figure S13. Photos of control mice (right panel) and PLL22-Gua-treated mice (left panel).
Treatment with 200 mg/kg of polymer did not affect the normal growth of fur and the body
weight of mice from both groups showed no significant difference.
Figure S14. H&E staining of normal tissues from control mice and PLL22-Gua treated mice.
The treatment with the polypeptide did not cause any damage to healthy tissues.
10